Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Sanjiv S. Agarwala, MD

Video Categories: Value

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.
November 3, 2014

New Data on PV Studies

Listen as Dr. Mesa discusses exciting new data in polycythemia vera on studies on hydrea coming out of ASCO and ASH.Supported through funding from Incyte

August 30, 2018

The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung Cancer

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.